Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.
about
Developing stem cell therapies for juvenile and adult-onset Huntington's diseaseAdult neural stem cells: an endogenous tool to repair brain injury?Pluripotent stem cells models for Huntington's disease: prospects and challengesThe glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's diseasePrion-like transmission of protein aggregates in neurodegenerative diseasesIntrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.Stem Cells Transplantation and Huntington's DiseaseCell Therapy Strategies vs. Paracrine Effect in Huntington's Disease.Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implicationsOmental transplantation for neurodegenerative diseasesProducing striatal phenotypes for transplantation in Huntington's disease.Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's disease.The biology of proteostasis in aging and disease.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics.Stem cells for cell replacement therapy: a therapeutic strategy for HD?The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A ReviewReductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.Stem cell pathologies and neurological diseaseCellular therapy and induced neuronal replacement for Huntington's disease.Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retinaG-protein-coupled receptors in adult neurogenesis.The emerging role of the first 17 amino acids of huntingtin in Huntington's diseaseCharacterization of Three-Dimensional Retinal Tissue Derived from Human Embryonic Stem Cells in Adherent Monolayer Cultures.Developments in intracerebral stem cell grafts.Translational research in Huntington's disease: opening up for disease modifying treatmentBone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions.Neurorehabilitation with neural transplantation.Molecular mechanisms and potential therapeutical targets in Huntington's disease.Experimental surgical therapies for Huntington's disease.Differential diagnosis of chorea.Pharmacologic approaches to the treatment of Huntington's disease.Intracerebral transplantation for neurological disorders. Lessons from developmental, experimental, and clinical studies.
P2860
Q26799722-4D843AD4-972F-407F-A09B-012DD6047044Q26829074-B0859500-F100-4025-81AF-574554300114Q26860151-E8DF35CE-B1C1-4145-8841-64A3F7D3E28EQ27023715-D6767B76-002C-4F31-88B4-098256417AE5Q28705237-F2CC119F-0DEC-4798-AC4B-2C1A333813AAQ33544162-F27BC29F-DD1A-4C3C-9F8E-C3BC64A4438BQ33551995-3FD8B8D2-B255-4DCF-9C93-6B1716194AB8Q33614689-9663290F-ADC1-4D3F-8CE4-3E9191AD3A1BQ33734410-52812383-EB4B-41B4-A925-15C1D6080FF6Q33788929-E288DD82-F909-45BC-8870-008480CA3557Q33995614-09CB000E-3CD0-4DD6-B331-64DECE7A9CC4Q34012297-09CA2C20-7134-45F8-BA82-58563994A258Q34172496-839D0CC0-35F7-4851-8CB6-B4CA550EE4D0Q34227112-17B5BFF0-C805-45F5-ACDA-FCA1190E6423Q34406937-997B7F8A-DAA3-454E-8EDD-DBBA3AA473D5Q34467650-5DAFF740-6D2A-4E9B-8541-6AB7886265F2Q34595662-41F793FA-138C-459C-AFD2-D95BEC82EDC0Q35220360-C7481D2F-F947-4F22-8D73-B8835197645DQ35250495-9A342B06-8F6C-43A4-AD29-B93AA14A99A6Q35597607-4292B369-C487-46F0-A757-CF6AE5DDB7AAQ35600187-3B59C052-01FB-4B4F-B9CF-E5C20A86642CQ35626316-29DDE1C9-A6A4-4CE3-A94D-C7380E35167AQ35648164-D9D09CF2-A6ED-40C5-9229-C9B33C9BF89EQ35648168-6590F0F8-400D-4DD9-BC7D-FE7E621480C9Q35910875-2F06AD77-A322-445E-8619-A15FE1CCE6DCQ36105469-278FF049-1F88-4573-8252-D555E60499EEQ36110838-BC60C017-A826-405E-A1B7-E96EF8FF066AQ36301644-1CE01108-8E4F-431B-AA56-C8B6A84B2268Q36377595-E6D628FF-C314-43F5-98F1-883859730F59Q36722683-6F43DAAF-D384-4347-B373-6C8BFF37C937Q37613043-F202B6B6-F064-418A-AC69-90B52BB0FFF3Q37643268-1D187C3D-5A15-4F5D-B2D1-4EFAA3497D33Q37652595-43DC5F4C-A3B0-49D0-9C67-C243EE8F1441Q37698259-FAF8821A-1366-4ACB-A9C9-CD5A8DBEB209Q37774495-AFA8A2A7-A8B7-4ED6-8A5F-D4E9ED2AC408Q37776087-57D9A09B-0009-4754-9786-19ACC93FEABCQ37825629-17301DF7-1019-474A-8525-C6FFF36CC737Q37861587-1B06F3C0-10AD-493E-BD21-451947CD91E6Q37945478-F3241E02-37ED-44CC-AD06-86D64AD73672Q37982705-59719FDF-35D3-4E60-9AE6-0A2A3535F262
P2860
Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neural transplants in patients ...... se-like neuronal degeneration.
@en
Neural transplants in patients ...... se-like neuronal degeneration.
@nl
type
label
Neural transplants in patients ...... se-like neuronal degeneration.
@en
Neural transplants in patients ...... se-like neuronal degeneration.
@nl
prefLabel
Neural transplants in patients ...... se-like neuronal degeneration.
@en
Neural transplants in patients ...... se-like neuronal degeneration.
@nl
P2093
P2860
P356
P1476
Neural transplants in patients ...... se-like neuronal degeneration.
@en
P2093
E J Mufson
F Cicchetti
J H Kordower
J R Parker
M Saint-Pierre
P R Sanberg
R A Hauser
T B Freeman
P2860
P304
12483-12488
P356
10.1073/PNAS.0904239106
P407
P577
2009-07-20T00:00:00Z